Aspire Biopharma Holdings (ASBP) Preferred Shares (2022 - 2026)

Aspire Biopharma Holdings (ASBP) has reported Preferred Shares for 4 consecutive years, with $2.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Preferred Shares changed N/A year-over-year to $2.0 in Q2 2026; TTM through Jun 2026 was $2.0, a N/A change from a year earlier, with the FY2024 full-year figure at $32.0, down 100.0% from the prior year.
• Preferred Shares was $2.0 for Q2 2026 at Aspire Biopharma Holdings, up from $1.0 in the prior quarter.
• Over five years, Preferred Shares peaked at $5.0 million in Q4 2022 and troughed at $1.0 in Q1 2026.
• A 4-year average of $2.0 million and a median of $32.0 in 2024 frame the typical range for Preferred Shares.
• Across the five-year window, Preferred Shares changed 0.0% in 2023 and tumbled 100.0% in 2024, its largest moves.
• Over 4 years, Preferred Shares stood at $5.0 million in 2022, then changed by 0.0% to $5.0 million in 2023, then plunged by 100.0% to $32.0 in 2024, then plunged by 93.75% to $2.0 in 2026.
• The last three Preferred Shares figures came in at $2.0 (Q2 2026), $1.0 (Q1 2026), and $32.0 (Q4 2024), per Business Quant data.